Remy Cointreau SA
PAR:RCO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
36.26
64.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Remy Cointreau SA
Nestled in the charming landscape of France, Remy Cointreau SA stands as a paragon of luxury in the world of spirits. The company proudly traces its origins back to the early 18th century, when the Rémy Martin and Cointreau families began their storied journey in cognac and liqueur, respectively. Today, these illustrious brands have merged under the Remy Cointreau umbrella, creating a powerhouse in premium alcoholic beverages. This blend of historical pedigree and modern innovation has seen the firm evolve into an industry leader. Remy Cointreau’s adept mastery of the distillation process and their unwavering commitment to quality are at the heart of their operations. Every detail in the production process, from the meticulous selection of grapes in the Cognac region to the precise aging in oak barrels, reveals a steadfast dedication to creating exceptional spirits.
The financial heartbeat of Remy Cointreau revolves around its lucrative portfolio of high-end brands, each commanding a premium price point. The company generates revenue primarily by producing, marketing, and selling its distinguished spirits across the globe. While its flagship cognac, Rémy Martin, remains the crown jewel, other brands, including Cointreau liqueur and Mount Gay rum, add diversity and strength to their offerings. Remy Cointreau’s strategic focus on premiumization allows it to target affluent consumers and gain traction in emerging markets, enhancing its profitability margins. Furthermore, the company's astute geographic diversification ensures resilience, allowing it to withstand market fluctuations and capitalize on varying global demands. Through this blend of heritage, quality, and strategic foresight, Remy Cointreau has crafted a narrative of enduring success in a competitive industry.
Nestled in the charming landscape of France, Remy Cointreau SA stands as a paragon of luxury in the world of spirits. The company proudly traces its origins back to the early 18th century, when the Rémy Martin and Cointreau families began their storied journey in cognac and liqueur, respectively. Today, these illustrious brands have merged under the Remy Cointreau umbrella, creating a powerhouse in premium alcoholic beverages. This blend of historical pedigree and modern innovation has seen the firm evolve into an industry leader. Remy Cointreau’s adept mastery of the distillation process and their unwavering commitment to quality are at the heart of their operations. Every detail in the production process, from the meticulous selection of grapes in the Cognac region to the precise aging in oak barrels, reveals a steadfast dedication to creating exceptional spirits.
The financial heartbeat of Remy Cointreau revolves around its lucrative portfolio of high-end brands, each commanding a premium price point. The company generates revenue primarily by producing, marketing, and selling its distinguished spirits across the globe. While its flagship cognac, Rémy Martin, remains the crown jewel, other brands, including Cointreau liqueur and Mount Gay rum, add diversity and strength to their offerings. Remy Cointreau’s strategic focus on premiumization allows it to target affluent consumers and gain traction in emerging markets, enhancing its profitability margins. Furthermore, the company's astute geographic diversification ensures resilience, allowing it to withstand market fluctuations and capitalize on varying global demands. Through this blend of heritage, quality, and strategic foresight, Remy Cointreau has crafted a narrative of enduring success in a competitive industry.
Sales Decline: Group sales were €489.6 million, an organic decrease of 4.2% versus last year.
Profit Drop: Current operating profit fell 13.6% organically to €108.7 million, with margin down 2.7 points to 22.2%.
Cognac Weakness: Cognac sales remain soft, especially in China (mid-teens decline) and only partial recovery in the US, but some early signs of improvement are noted.
Cost & Margin Pressure: Gross margin contracted 2.4 points due to tariffs, unfavorable price/mix, and production cost inflation. A&P spending ratio increased to 19.4% of sales.
Cash Flow & Debt: Free cash flow was negative at €16.5 million; net financial debt rose to €686.7 million (net debt/EBITDA at 2.96).
Guidance Confirmed: Full-year guidance maintained: organic sales growth expected to be flat to low single digit, COP to decline by low double digits to mid-teens.
Transformation Agenda: New CEO is launching a transformation focused on revitalizing Cognac, accelerating Liqueurs & Spirits, driving cash generation, and reassessing strategy.
Portfolio & Pricing Flexibility: Management is reviewing pricing strategy, portfolio complexity, and considering more pragmatic, less dogmatic approaches to stimulate volume and cash flow.